<DOC>
	<DOCNO>NCT00796913</DOCNO>
	<brief_summary>ATD therapy Graves ' disease one commonly use option therapy hyperthyroidism . The investigator study optimally keep patient remission .</brief_summary>
	<brief_title>Remission Induction Sustenance Graves ' Disease 2</brief_title>
	<detailed_description>A detailed description patient enter initial observational phase study ( RISG1 ) publish : Laurberg P , Nygaard B , Andersen S , Carl√© A , Karmisholt J , Krejbjerg A , Pedersen IB , Andersen SL . Association TSH-Receptor Autoimmunity , Hyperthyroidism , Goitre , Orbitopathy 208 Patients Included Remission Induction Sustenance Graves ' Disease Study . J Thyroid Res . 2014 ; 2014:165487. doi : 10.1155/2014/165487 .</detailed_description>
	<mesh_term>Graves Disease</mesh_term>
	<mesh_term>Hyperthyroidism</mesh_term>
	<criteria>Graves hyperthyroidism remission ATD Age &lt; 18 , severe concomitant disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>